InvestorsHub Logo
Followers 43
Posts 4307
Boards Moderated 0
Alias Born 09/01/2017

Re: br8k0ut post# 457168

Wednesday, 04/06/2022 2:51:29 AM

Wednesday, April 06, 2022 2:51:29 AM

Post# of 701090
$34 per share is a lot better than we’re at now, and I wouldn’t blame anyone to cash out some shares even at a third or more of that price, or even cash out completely if that provides peace of mind.

In my opinion if dcvax results look shockingly good and there is good press that whips up a feeding frenzy, there could be a short term overreaction shooting the share price to $34 or a bit more. This has happened with other stock, rising irrationally for a day or three before sanity is restored

However, if dcvax is successful as a platform technology for a number of different malignancies, the long term potential can be over $100 billion to multiples of hundreds of billions.

At today’s number of shares outstanding (let’s say a billion shares) that market cap would put the share price in the $100 - $500 per share range or maybe higher longer term. This would put nwbo in the class of biggest pharma like a Merck or larger, and years down the road if ever.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News